본문 바로가기
KERD
논문KCI 등재

Induction of Apoptosis by Ethyl Acetate Fraction of Astragalus membranaceus in Human Non-small Cell Lung Cancer Cells - Apoptosis Induction by

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives: The purpose of this study is to investigate the anti-cancer effects of different fractions of Astragalus membranaceus (AM) in human non-small cell lung cancer (NSCLC) cells. Methods: We isolated hexane, ethyl acetate, and butanol fractions from crude ethanol extract of AM. The cell death was examined by MTT assay and trypan blue exclusion assay. Apoptosis was detected by DAPI staining, annexin V-PI double staining and cell cycle analysis. The expression of apoptosis-related proteins and mitogen-activated protein kinases (MAPKs) was examined by western blot. Results: Among various fractions of AM, the ethyl acetate fraction of AM (EAM) showed the strongest cytotoxic effect in NSCLC cells. EAM reduced the cell proliferation in a time- and dose-dependent manner in NSCLC cells. In addition, EAM induced the chromatin condensation, and increased the population of sub-G1 phase and annexin V-positive cells in a time-dependent manner, indicating that EAM induced apoptosis in NSCLC cells. Consistently, EAM enhanced the expression of cleaved caspase-8 and -9, and induced the accumulation of cleaved- poly (ADP-ribose) polymerase (PARP). Among MAPK proteins, only ERK was dephosphorylated by EAM, suggesting that ERK might be related with EAM-induced apoptosis. Conclusion: Our results clearly demonstrate that EAM exhibited anti-cancer effects in NSCLC cells by induction of apoptosis. We provide a valuable evidence which suggests that AM could be a desirable therapeutic option for treatment of NSCLC.

Abstract

Objectives: The purpose of this study is to investigate the anti-cancer effects of different fractions of Astragalus membranaceus (AM) in human non-small cell lung cancer (NSCLC) cells. Methods: We isolated hexane, ethyl acetate, and butanol fractions from crude ethanol extract of AM. The cell death was examined by MTT assay and trypan blue exclusion assay. Apoptosis was detected by DAPI staining, annexin V-PI double staining and cell cycle analysis. The expression of apoptosis-related proteins and mitogen-activated protein kinases (MAPKs) was examined by western blot. Results: Among various fractions of AM, the ethyl acetate fraction of AM (EAM) showed the strongest cytotoxic effect in NSCLC cells. EAM reduced the cell proliferation in a time- and dose-dependent manner in NSCLC cells. In addition, EAM induced the chromatin condensation, and increased the population of sub-G1 phase and annexin V-positive cells in a time-dependent manner, indicating that EAM induced apoptosis in NSCLC cells. Consistently, EAM enhanced the expression of cleaved caspase-8 and -9, and induced the accumulation of cleaved- poly (ADP-ribose) polymerase (PARP). Among MAPK proteins, only ERK was dephosphorylated by EAM, suggesting that ERK might be related with EAM-induced apoptosis. Conclusion: Our results clearly demonstrate that EAM exhibited anti-cancer effects in NSCLC cells by induction of apoptosis. We provide a valuable evidence which suggests that AM could be a desirable therapeutic option for treatment of NSCLC.

참고문헌 (33)

  1. Visbal AL, "Gender differences in non-smallcell lung cancer survival : an analysis of 4618 patients diagnosed between 1997 and 2002", Ann Thorac Surg, 78, pp.209~215 (2004)
  2. Keith R, "Lung cancer chemoprevention : current status and future prospects", Nat Rev Clin Oncol, 10, pp.334~343 (2013)
  3. Zappa C, "Non-small cell lung cancer : current treatment and future advances", Transl Lung Cancer Res, 5(3), pp.288~300 (2016)
  4. Ramalingam S, "Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions", Oncologist, (Suppl 1), pp.S5~S13 (2008)
  5. Blackhall FH, "Improving survival and reducing toxicity with chemotherapy in advanced nonsmall cell lung cancer: a realistic goal?", Treat Respir Med, 4, pp.71~84 (2005)
  6. Wolf BB, "Suicidal tendencies : apoptotic cell death by caspase family proteinases", Journal of Biological Chemistry, 274, pp.20049~20052 (1999)
  7. Susin SA, "Two distinct pathways leading to nuclear apoptosis", Journal of Experimental Medicine, 192, pp.571~580 (2000)
  8. Makin G, "Apoptosis and cancer chemotherapy", Cell Tissue Res, 301(1), pp.143~152 (2000)
  9. Auyeung KK, "Astragalus membranaceus : a review of its protection against inflammation and gastrointestinal cancers", Am J Chin Med, 44(1), pp.1~22 (2016)
  10. Ma Y, "Antibacterial evaluation of sliver nanoparticles synthesized by polysaccharides from Astragalus membranaceus roots", Biomed Pharmacother, 89, pp.351~357 (2017)
  11. Zhu J, "Effects and mechanism of flavonoids from Astragalus complanatus on breast cancer growth", Naunyn Schmiedeberg's Arch Pharmacol, 388(9), pp.965~972 (2015)
  12. Wang Y, "Astragalus saponins modulates colon cancer development by regu-lating calpain-mediated glucose-regulated protein expression", BMC Complement Altern Med, 14, pp.401~ (2014)
  13. Denzler K, "Characterization of the physiological response following in vivo administration of Astragalus membranaceus", Evidence-based complementary and alternative medicine, pp.6861078~ (2016)
  14. Wang Z, "Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer", BMC Complement Altern Med, 29(5), pp.1473~1482 (2016)
  15. Huang WH, "Astragalus polysaccharide induces the apoptosis of human hepatocellular carcinoma cells by decreasing the expression of Notch1", Int J Mol Med, 38(2), pp.551~557 (2016)
  16. Tseng A, "An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract", Oncol Rep, 35(2), pp.659~668 (2016)
  17. Lai X, "Therapeutic effect of Astragalus polysaccharides on hepatocellular carcinoma H22-bearing mice", Dose-response, 15(1), pp.1~6 (2017)
  18. Zhou Z, "Chemosensitizing effect of Astragalus polysaccharides on nasopharyngeal carcinoma cells by inducing apoptosis and modulating expression of Bax", Bcl-2 ratio and caspases, 2017, pp.23, 462~469
  19. Cheng XD, "Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKCalpha", ERK1, Mol Med Rep, pp.2015, 12(6)[DOI]
  20. Jia L, "Astragaloside IV inhibits the progression of non-small cell lung cancer through Akt", GSK-3β, Oncol Res, pp.2018, 21[DOI]
  21. He CS, "Astragaloside IV Enhances Cisplatin Chemosensitivity in Non-Small Cell Lung Cancer Cells Through Inhibition of B7-H3", Cell Physiol Biochem, 40(5), pp.1221~1229 (2016)
  22. Yang Y, "Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis", Int J Clin Exp Pathol, 7(12), pp.8453~8461 (2014)
  23. Zhang A, "Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO", J Cancer Res Clin Oncol, 140(11), pp.1883~1890 (2014)
  24. Guo L, "Astragalus polysaccharide injection integrated with vinorelbine and cisplatin for patients with advanced non-small cell lung cancer : effects on quality of life and survival", Med Oncol, 29(3), pp.1656~1662 (2012)
  25. Wang SF, "Astragalus-containing traditional Chinese medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer : a systemic review and meta-analysis", Current oncology, 23(3), pp.188~195 (2016)
  26. Liu SQ, "Clinical application of the theory of the attributive channel of traditional Chinese medicine", Zhong Yao Tong Bao, 11, pp.56~58 (1986)
  27. Wolf BB, "Suicidal tendencies : apoptotic cell death by caspase family proteinases", J Biol Chem, 274, pp.20049~20052 (1999)
  28. Ouyang L, "Programmed cell death pathways in cancer : a review of apoptosis, autophagy and programmed necrosis", Cell Prolif, 45(6), pp.487~498 (2012)
  29. Wada T, "Mitogen-activated protein kinases in apoptosis regulation", Oncogene, 23(16), pp.2838~2849 (2004)
  30. Lu Z, "ERK1", 2 MAP kinases in cell survival and apoptosis, 2006, pp.58(11), 621~631
  31. Kim EJ, "Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK(Raf", mitogen-activated extracellular signal-regulated kinase, J Biol Chem, pp.2015, 290(15)[DOI]
  32. Li H, "Blocking the PI3K", AKT and MEK, Adv Med Sci, pp.2011, 56(2)[DOI]
  33. Lu JJ, "Melatonin inhibits AP-2β", hTERT, NF-κB, ERK and activates caspase, pp.Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells, Oncotarget[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (8건)